TRAVERE THERAPEUTICS INC: Ownership & Insider Activity
Hedge funds and institutional managers reporting a position in TRAVERE THERAPEUTICS INC. Based on the most recent 13F filing from each holder, sourced from SEC EDGAR.
Reported Holders
6
13F filers
Aggregate Value
$35.7M
Across holders
Last Price
—
EOD close
Sector
—
GICS
| Manager⇅ | Type⇅ | Shares⇅ | Market Value▼ | % of Total⇅ | % of Portfolio⇅ | Action⇅ | QoQ Change⇅ | Quarter⇅ |
|---|---|---|---|---|---|---|---|---|
| CITADEL ADVISORS LLC CIK 0001423053 | Hedge Fund | 11.75M | $13.8M | 38.7% | 0.0% | New | — | Q2 2026 |
| SHAW D E & CO INC CIK 0001009207 | Hedge Fund | 6.50M | $7.6M | 21.4% | 0.0% | New | — | Q2 2026 |
| ORBIMED ADVISORS LLC CIK 0001055951 | Hedge Fund | 5.00M | $5.9M | 16.5% | 0.1% | New | — | Q2 2026 |
| MILLENNIUM MANAGEMENT LLC CIK 0001273087 | Hedge Fund | 4.75M | $5.6M | 15.7% | 0.0% | New | — | Q2 2026 |
| Man Group plc CIK 0001637460 | Hedge Fund | 1.85M | $2.2M | 6.1% | 0.0% | New | — | Q2 2026 |
| TWO SIGMA INVESTMENTS, LP CIK 0001179392 | Hedge Fund | 500K | $588K | 1.6% | 0.0% | New | — | Q2 2026 |
New
Hedge Fund
$13.8M· 38.7% of total· 0.0% port· 11.75M sh· — QoQ· Q2 2026
New
Hedge Fund
$7.6M· 21.4% of total· 0.0% port· 6.50M sh· — QoQ· Q2 2026
New
Hedge Fund
$5.9M· 16.5% of total· 0.1% port· 5.00M sh· — QoQ· Q2 2026
New
Hedge Fund
$5.6M· 15.7% of total· 0.0% port· 4.75M sh· — QoQ· Q2 2026
New
Hedge Fund
$2.2M· 6.1% of total· 0.0% port· 1.85M sh· — QoQ· Q2 2026
New
Hedge Fund
$588K· 1.6% of total· 0.0% port· 500K sh· — QoQ· Q2 2026